Repro Med Correlations
KRMD Stock | USD 3.66 0.14 3.98% |
The current 90-days correlation between Repro Med Systems and Precision Optics, is 0.23 (i.e., Modest diversification). The correlation of Repro Med is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Repro Med Correlation With Market
Significant diversification
The correlation between Repro Med Systems and DJI is 0.01 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Repro Med Systems and DJI in the same portfolio, assuming nothing else is changed.
Repro |
Moving together with Repro Stock
0.72 | DOCS | Doximity | PairCorr |
0.76 | FOXO | FOXO Technologies | PairCorr |
0.7 | ITGR | Integer Holdings Corp | PairCorr |
0.83 | MMSI | Merit Medical Systems | PairCorr |
0.75 | OMIC | Singular Genomics Systems | PairCorr |
0.8 | CRVL | CorVel Corp | PairCorr |
0.75 | EXEL | Exelixis | PairCorr |
0.8 | BMY | Bristol Myers Squibb Sell-off Trend | PairCorr |
Moving against Repro Stock
0.85 | EVH | Evolent Health | PairCorr |
0.84 | AMN | AMN Healthcare Services | PairCorr |
0.76 | AGL | agilon health Buyout Trend | PairCorr |
0.62 | PHG | Koninklijke Philips | PairCorr |
0.57 | FORA | Forian Inc | PairCorr |
0.51 | IVP | Inspire Veterinary | PairCorr |
0.48 | FIGS | Figs Inc | PairCorr |
0.81 | VALN | Valneva SE ADR | PairCorr |
0.71 | ADUS | Addus HomeCare | PairCorr |
0.7 | ME | 23Andme Holding | PairCorr |
0.63 | BACK | IMAC Holdings | PairCorr |
0.58 | EQ | Equillium | PairCorr |
0.52 | CYRX | Cryoport | PairCorr |
0.49 | ATPC | Agape ATP | PairCorr |
0.46 | A | Agilent Technologies | PairCorr |
0.34 | DOMH | Dominari Holdings | PairCorr |
0.33 | VCNX | Vaccinex | PairCorr |
0.87 | LLY | Eli Lilly | PairCorr |
0.82 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.79 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.73 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
0.55 | HLN | Haleon plc | PairCorr |
0.53 | EXAS | EXACT Sciences | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Repro Stock performing well and Repro Med Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Repro Med's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
POCI | 3.45 | (0.08) | (0.02) | 0.05 | 4.06 | 7.48 | 18.59 | |||
INFU | 3.05 | 0.47 | 0.17 | 0.36 | 2.71 | 7.64 | 22.10 | |||
UTMD | 0.71 | (0.15) | 0.00 | (0.06) | 0.00 | 1.17 | 7.07 | |||
MLSS | 2.97 | (0.44) | 0.00 | (0.33) | 0.00 | 8.45 | 27.59 | |||
MMSI | 0.88 | 0.13 | 0.08 | 0.37 | 0.71 | 2.11 | 6.42 | |||
ATRC | 1.92 | 0.47 | 0.26 | 0.50 | 1.39 | 4.67 | 23.09 | |||
BDXB | 0.40 | (0.03) | 0.00 | (0.25) | 0.00 | 0.76 | 4.00 | |||
PDEX | 4.07 | 1.20 | 0.22 | 0.92 | 4.38 | 10.44 | 30.21 | |||
ATRI | 0.39 | (0.01) | 0.00 | 0.42 | 0.00 | 0.94 | 6.29 |
Repro Med Corporate Management
Brian Case | Chief Officer | Profile | |
Thomas Adams | Chief Officer | Profile | |
Rob Cannon | Vice Sales | Profile | |
Josh Bennett | VP Devel | Profile | |
Kenneth Miller | Chief Officer | Profile | |
Tom Adams | Interim Officer | Profile |